Impact of ketosis on appetite regulation-a review.


Journal

Nutrition research (New York, N.Y.)
ISSN: 1879-0739
Titre abrégé: Nutr Res
Pays: United States
ID NLM: 8303331

Informations de publication

Date de publication:
05 2020
Historique:
received: 08 10 2019
revised: 30 01 2020
accepted: 18 02 2020
pubmed: 21 3 2020
medline: 26 5 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

To reduce the health burden of obesity, it is important to identify safe and practical treatments that are effective for weight loss while concurrently preventing weight regain. Diet-induced weight loss is usually followed by a concomitant increase in ghrelin secretion and feelings of hunger, which may compromise weight loss goals and increase the risk of weight regain. The aim of this review is to describe the status of knowledge regarding the impact of ketosis, induced by diet or exogenous ketones (ketone esters), on appetite and the potential mechanisms involved. Ketogenic diets (KDs) have been shown to prevent an increase in ghrelin secretion, otherwise seen with weight loss, as well as to reduce hunger and/or prevent hunger. However, the exact threshold of ketosis needed to induce appetite suppression, as well as the exact mechanisms that mediate such an effect, has yet to be elucidated. Use of exogenous ketones may provide an alternative to KDs, which have poor long-term adherence due to their restrictive nature. Ketone esters have been shown to have concentration-dependent effects on food intake and body weight in rodent models, with effects becoming apparent when 30% of total dietary energy comes from ketone esters (threshold effect). In humans, acute consumption of a ketone ester drink reduced feelings of hunger and increased satiety compared to a dextrose drink. With the emerging widespread acceptance of KDs and exogenous ketones in mainstream media and the diet culture, it is important to fully understand their role on appetite control and weight management and the potential mechanisms mediating this role.

Identifiants

pubmed: 32193016
pii: S0271-5317(19)30937-6
doi: 10.1016/j.nutres.2020.02.010
pii:
doi:

Substances chimiques

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate 0
Esters 0
Ghrelin 0
Hydroxybutyrates 0
Ketones 0
3-Hydroxybutyric Acid TZP1275679

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Subventions

Organisme : NIDDK NIH HHS
ID : T32 DK062710
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Sarah E Deemer (SE)

Department of Nutrition Sciences and Nutrition Obesity Research Center, The University of Alabama at Birmingham (UAB), Birmingham, AL, USA.

Eric P Plaisance (EP)

Department of Human Studies, Exercise Physiology, Nutrition Obesity Research Center, The University of Alabama at Birmingham (UAB), Birmingham, AL, USA.

Catia Martins (C)

Department of Nutrition Sciences and Nutrition Obesity Research Center, The University of Alabama at Birmingham (UAB), Birmingham, AL, USA; Obesity Research Group, Department of Clinical Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Centre for Obesity and Innovation (ObeCe), Clinic of Surgery, St Olav University Hospital, Trondheim, Norway. Electronic address: catia.martins@ntnu.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH